Clinical Trials Commence With Sytrinol

SourceOne™ Global Partners has announced the commencement of clinical trials on their new product, Sytrinol. If Syntrinol passes the test, it will be sold as a cardiovascular agent used for cardiovascular health. Sytrinol is a powerful antioxidant that contains phytosterols, which are compounds found in plants. Previous studies have revealed the heart-healthy benefits of phytosterols in lowering total and LDL cholesterol levels. Unfortunately, it has been noted that phytosterols only block the absorption of cholesterol acquired through food consumption and not the cholesterol made by the liver, which is usually the culprit of high cholesterol levels. SourceOne™ states that the special formulation of Sytrinol does prevent the absorption of cholesterol made by the liver as well.Read more about this.